Management of Tubo-ovarian Abscess: a Single Center Experience

Sisli Hamidiye Etfal Training and Research Hospital

Status: Completed

Conditions: Tubo-ovarian Abscess

Treatments: Other: tuboovarian abscess

Study type: Observational

Funder types: Other

Identifiers

NCT04817631

TOA

Details and patient eligibility

About

Electronic database of our tertiary obstetrics and gynecology clinic was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities.

Full description

This retrospective study is conducted at Health Sciences University Turkey, Sisli Hamidiye Etfal Training and Research Hospital Department of Obstetrics and Gynecology. Electronic database was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities. A change in management strategy over the years if any will be reported.

Enrollment: 82 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• presence of a pelvic mass > 3 cm with transvaginal ultrasound or magnetic resonance imaging indication abscess
• cervical and uterine tenderness
• abdominal rebound-defense under physical examination indication peritoneal irritation
• presence of symptoms such as fever, pelvic pain and increase in laboratory infection parameters

Exclusion criteria

• Patients with known malignities
• Patients with incomplete data in the clinic's electronic database
• Patients who continued their treatment at other centers